Literature DB >> 7097822

MAS trousers improperly applied causing a compartment syndrome in lower-extremity trauma.

S Brotman, B D Browner, E F Cox.   

Abstract

A case is presented in which the leg segments of MAS trousers were deflated without deflating the abdominal segment, causing the trousers to act as a venous tourniquet. As a result bleeding and edema secondary to a pertrochanteric hip fracture were aggravated, causing a compartment syndrome in the thigh; fasciotomy became necessary. MAS trousers must be inflated in proper sequence, the leg segments first and then the abdominal portion. In deflation, the order is reversed. Only if this sequence is followed can MAS trousers be used safely.

Entities:  

Mesh:

Year:  1982        PMID: 7097822     DOI: 10.1097/00005373-198207000-00014

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  3 in total

1.  Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.

Authors:  Shuai Wang; Tong Dai; Ziran Qin; Ting Pan; Feng Chu; Lingfeng Lou; Long Zhang; Bing Yang; Huizhe Huang; Huasong Lu; Fangfang Zhou
Journal:  Nat Cell Biol       Date:  2021-07-08       Impact factor: 28.824

2.  Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.

Authors:  Anastasiya Belyaeva; Louis Cammarata; Adityanarayanan Radhakrishnan; Chandler Squires; Karren Dai Yang; G V Shivashankar; Caroline Uhler
Journal:  Nat Commun       Date:  2021-02-15       Impact factor: 14.919

3.  Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.

Authors:  Mingfeng Han; Mengyuan Xu; Yafei Zhang; Zhongping Liu; Shasha Li; Mengji Lu; Zhenhua Zhang; Tengfei He; Jinsong Li; Yong Gao; Wanjun Liu; Tuantuan Li; Zixiang Chen; Xin Huang; Guoling Cheng; Jun Wang; Ulf Dittmer; Oliver Witzke; Guizhou Zou; Xiuyong Li
Journal:  Med Microbiol Immunol       Date:  2020-08-28       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.